Rankings
▼
Calendar
SMMT Q4 2023 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$840,000
Operating Income
-$28M
Net Income
-$29M
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$203M
Total Liabilities
$125M
Stockholders' Equity
$78M
Cash & Equivalents
$71M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$705
-100.0%
Gross Profit
-$840,000
-$595,000
-41.2%
Operating Income
-$28M
-$20M
-39.9%
Net Income
-$29M
-$19M
-49.2%
← FY 2023
All Quarters
Q1 2024 →